Quiz collegato alla guida · Difficile Livello
Quiz sull'intelligenza artificiale in farmacogenomica
Metti alla prova la tua comprensione degli alleli stellari e dei punteggi di attività, di come CPIC trasforma i fenotipi in azioni di prescrizione e della fenoconversione da farmaci interagenti.
Domanda 1 di 8
Esiste una linea guida CPIC per una coppia gene-farmaco. Secondo la guida, a quale domanda risponde?
Anteprima di ogni domanda8 domande
Le risposte e le spiegazioni vengono visualizzate mentre rispondi al quiz.
- Esiste una linea guida CPIC per una coppia gene-farmaco. Secondo la guida, a quale domanda risponde?
- Whether a clinician should order the genetic test
- How to adjust prescribing once a test result is already available
- Which lab should run the test
- How much the test should cost
- Il genotipo di un paziente mostra una normale funzione CYP2D6, ma assume paroxetina. Cosa dovrebbe considerare il farmacista?
- The patient may behave like a poor metabolizer because of phenoconversion
- The genotype result must be a lab error
- Paroxetine is removed from the body entirely through CYP2C19
- The patient is automatically an ultrarapid metabolizer
- Perché la guida mette in guardia contro la somministrazione di codeina a un metabolizzatore ultrarapido CYP2D6?
- Codeine does nothing at all in these patients
- They turn codeine into morphine quickly, which risks toxicity
- Codeine permanently blocks the CYP2D6 gene
- The HLA-B gene forbids it
- Come viene calcolato il punteggio di attività CYP2D6, come descritto nella guida?
- By counting the patient's current medications
- By measuring morphine in a blood sample
- By adding the activity values assigned to the two star alleles
- By averaging results from three separate labs
- Cosa rende il CYP2D6 particolarmente difficile da richiamare dal sequenziamento a lettura breve?
- It sits on the Y chromosome only
- It has no known variants
- Deletions, extra copies and hybrids with the similar CYP2D7 pseudogene
- It is only expressed in the brain
- Which misconception about pharmacogenomic panels does the guide correct?
- That they can show which antidepressant will work for a person
- That they involve DNA
- That CYP2C19 affects clopidogrel
- That HLA-B variants relate to drug reactions
- Why might a targeted genotyping panel wrongly report a normal-function *1 allele?
- It sequences every base of the gene twice
- It only tests preselected variants, so an untested rare variant goes unseen
- It always reports *1 for women
- It relies on the patient's family history
- The guide says decision-support systems often store a coded phenotype rather than raw variants. What maintenance risk does this create?
- Phenotypes take up too much storage
- Stored phenotypes can become outdated when CPIC changes its translation tables
- Coded phenotypes cannot trigger alerts
- Pharmacists are not allowed to read phenotypes